Characterization of aluminium-containing adjuvants

Area of Science:

• Vaccine adjuvant technology
• Materials science
• Immunology

Background:

• Approved aluminium-containing vaccine adjuvants include poorly crystalline aluminium oxyhydroxide (AIO(OH)) and amorphous aluminium hydroxyphosphate.
• Antigen adsorption by adjuvants is a proposed mechanism for enhancing antibody production.
• The World Health Organization recommends high antigen adsorption rates (≥80%) for tetanus and diphtheria toxoids.

Purpose of the Study:

• To optimize antigen adsorption onto aluminium-containing vaccine adjuvants.
• To facilitate consistent adjuvant effects in vaccines through thorough adjuvant characterization.
• To understand and predict adjuvant-antigen interactions in vaccine formulations.

Main Methods:

• Characterization of aluminium adjuvants using techniques like X-ray diffraction, infrared spectroscopy, and transmission electron microscopy.
• Analysis of surface properties including surface area, surface charge, chemical composition, structure, and morphology.
• Utilizing methods such as Doppler electrophoretic light scattering, dissolution rate studies, and adsorption isotherms.

Main Results:

• Established a basis for understanding adjuvant colloidal behavior and antigen interactions.
• Provided insights into properties affecting antigen adsorption, crucial for vaccine formulation.
• Demonstrated the utility of various analytical techniques for adjuvant characterization.

Conclusions:

• Thorough characterization of aluminium adjuvants is essential for optimizing antigen adsorption.
• Understanding adjuvant properties aids in predicting and ensuring consistent vaccine efficacy.
• These characterization methods are crucial for vaccine standardization and quality control.